Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies for all GLP-1s, including Saxenda, Trulicity and Mounjaro. Semaglutide is ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

Weight loss drug Ozempic has caused quite a stir this year, with many linking it to drastic celebrity weight loss. While ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...

Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.